Article Versions Notes

Fang X, Cui S, Lee H, Min JW, Lim SW, Oh E-J, Yang CW, Shin YJ, Chung BH. Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model. International Journal of Molecular Sciences. 2024; 25(3):1378. https://doi.org/10.3390/ijms25031378

Fang, Xianying, Sheng Cui, Hanbi Lee, Ji Won Min, Sun Woo Lim, Eun-Jee Oh, Chul Woo Yang, Yoo Jin Shin, and Byung Ha Chung. 2024. "Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model" International Journal of Molecular Sciences 25, no. 3: 1378. https://doi.org/10.3390/ijms25031378

Fang, X., Cui, S., Lee, H., Min, J. W., Lim, S. W., Oh, E. -J., Yang, C. W., Shin, Y. J., & Chung, B. H. (2024). Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model. International Journal of Molecular Sciences, 25(3), 1378. https://doi.org/10.3390/ijms25031378